Drug-coated balloon angioplasty for severe pulmonary vein stenosis resulting from cryoballoon ablation for atrial fibrillation

• DOI: 10.1016/j.jccase.2022.02.009
• Publication Date: 2022-03-29T21:27:55Z
• Authors: Koji Yamaguchi; Tetsuzo Wakatsuki; Tomomi Matsuura; Kazuhisa Matsumoto; Yutaka Kawabata; Muneyuki Kadota; Kenya Kusunose; Takayuki Ise; Shusuke Yagi; Daiju Fukuda; Hirotsugu Yamada; Takeshi Soeki; Masataka Sata
• Keywords: Pulmonary vein stenosis

We performed a drug-coated balloon (DCB) angioplasty for severe pulmonary vein (PV) stenosis resulting from cryoballoon ablation for atrial fibrillation. Three and 14 months after the angioplasty, follow-up multidetector computed tomography did not show restenosis. Lesion regression was observed at 14-month follow-up. Two years after PV angioplasty with DCB, the patient was well without any symptoms. DCB angioplasty may become an alternative effective procedure for PV stenosis. Learning objective: The usefulness and safety of DCB for severe pulmonary vein stenosis resulting from cryoballoon ablation for atrial fibrillation was observed at 14-month follow-up.